Superb Microvascular Imaging in Pediatric Focal Nodular Hyperplasia.


Journal

Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928

Informations de publication

Date de publication:
19 Feb 2024
Historique:
received: 19 04 2023
accepted: 02 01 2024
medline: 26 2 2024
pubmed: 26 2 2024
entrez: 26 2 2024
Statut: aheadofprint

Résumé

To investigate superb microvascular imaging (SMI), a novel Doppler ultrasound technique that can visualize low-velocity microvascular flow, for assessing pediatric focal nodular hyperplasia (FNH). Nine FNH lesions in 6 patients were enrolled. On SMI and color Doppler imaging (CDI), intralesional vascularity was assessed visually and categorized as typical spoke-wheel pattern (central vessel radiating from the center to the periphery), multifocal spoke-wheel pattern, and nonspecific pattern. We compared the vascular features of the lesions between SMI and CDI and evaluated vascular patterns according to lesion size. In terms of vascularity pattern, the typical spoke-wheel pattern of FNH was noted more frequently on SMI (67%) than on CDI (11%; P < 0.05). In addition, a multifocal spoke-wheel pattern was noted in all remaining lesions (33%) on SMI. On the contrary, a nonspecific vascular pattern was detected in the majority (78%) of CDI. Regarding the lesion size and vascularity on SMI, the typical spoke-wheel pattern was seen more frequently in the small FNH group than in the large FNH group. The intralesional vascular signal was detected more frequently on SMI (100%) than on CDI (89%). SMI is feasible in evaluating FNH in children and has a greater ability to demonstrate the spoke-wheel pattern than CDI.

Identifiants

pubmed: 38408130
doi: 10.1097/MPH.0000000000002826
pii: 00043426-990000000-00376
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Stocker JT, Ishak KG. Focal nodular hyperplasia of the liver: a study of 21 pediatric cases. Cancer. 1981;48:336–345.
Bouyn CI, Leclere J, Raimondo G, et al. Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer. 2003;97:3107–3113.
Towbin AJ, Luo GG, Yin H, et al. Focal nodular hyperplasia in children, adolescents, and young adults. Pediatr Radiol. 2011;41:341–349.
Cha DI, Yoo SY, Kim JH, et al. Clinical and imaging features of focal nodular hyperplasia in children. AJR Am J Roentgenol. 2014;202:960–965.
Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology. 1985;5:1194–1200.
Mathieu D, Vilgrain V, Mahfouz AE, et al. Benign liver tumors. Magn Reson Imaging Clin N Am. 1997;5:255–288.
Pen JH, Pelckmans PA, van Maercke YM, et al. Clinical significance of focal echogenic liver lesions. Gastrointest Radiol. 1986;11:61–66.
Yoo SY, Kim JH, Eo H, et al. Dynamic MRI findings and clinical features of benign hypervascular hepatic nodules in childhood cancer survivors. AJR Am J Roentgenol. 2013;201:178–184.
Joyner BL Jr, Levin TL, Goyal RK, et al. Focal nodular hyperplasia of the liver: a sequela of tumor therapy. Pediatr Radiol. 2005;35:1234–1239.
Marabelle A, Campagne D, Dechelotte P, et al. Focal nodular hyperplasia of the liver in patients previously treated for pediatric neoplastic diseases. J Pediatr Hematol Oncol. 2008;30:546–549.
Anderson L, Gregg D, Margolis D, et al. Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series. Bone Marrow Transplant. 2010;45:1357–1359.
Shirkhoda A, Farah MC, Bernacki E, et al. Hepatic focal nodular hyperplasia: CT and sonographic spectrum. Abdom Imaging. 1994;19:34–38.
Golli M, Mathieu D, Anglade MC, et al. Focal nodular hyperplasia of the liver: value of color Doppler US in association with MR imaging. Radiology. 1993;187:113–227.
Hussain SM, Terkivatan T, Zondervan PE, et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics. 2004;24:3–17.
Bertin C, Egels S, Wagner M, et al. Contrast-enhanced ultrasound of focal nodular hyperplasia: a matter of size. Eur Radiol. 2014;24:2561–2571.
Piscaglia F, Lencioni R, Sagrini E, et al. Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol. 2010;36:531–550.
D’Onofrio M, Crosara S, De Robertis R, et al. Contrast-enhanced ultrasound of focal liver lesions. AJR Am J Roentgenol. 2015;205:W56–W66.
Corvino A, Catalano O, Corvino F, et al. A diagnostic performance and confidence of contrast-enhanced ultrasound in the differential diagnosis of cystic and cystic-like liver lesions. AJR Am J Roentgenol. 2017;209:W119–W127.
Ma Y, Li G, Li J, et al. The diagnostic value of superb microvascular imaging (SMI) in detecting blood flow signals of breast lesions: a preliminary study comparing SMI to color Doppler flow imaging. Medicine (Baltimore). 2015;94:e1502.
Machado P, Segal S, Lyshchik A, et al. A novel microvascular flow technique: initial results in thyroids. Ultrasound Q. 2016;32:67–74.
Lee YS, Kim MJ, Han SW, et al. Superb microvascular imaging for the detection of parenchymal perfusion in normal and undescended testes in young children. Eur J Radiol. 2016;85:649–656.
Lee DH, Lee JY, Han JK. Superb microvascular imaging technology for ultrasound examinations: Initial experiences for hepatic tumors. Eur J Radiol. 2016;85:2090–2095.
Bonacchi G, Becciolini M, Seghieri M. Superb microvascular imaging: a potential tool in the detection of FNH. J Ultrasound. 2017;20:179–180.
Naganuma H, Ishida H, Ogawa M, et al. Visualization of draining vein in focal nodular hyperplasia by superb microvascular imaging: report of two cases. J Med Ultrason. 2017;44:323–328.
Kang TW, Jeong WK, Kim YY, et al. Comparison of super-resolution US and contrast material–enhanced US in detection of the spoke wheel sign in patients with focal nodular hyperplasia. Radiology. 2021;298:82–90.
Vilgrain V, Flejou JF, Arrive L, et al. Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology. 1992;184:699–703.
Campos JT, Sirlin CB, Choi JY. Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas. Insights Imaging. 2012;3:451–474.
Mathieu D, Rahmouni A, Anglade MC, et al. Focal nodular hyperplasia of the liver: assessment with contrast-enhanced TurboFLASH MR imaging. Radiology. 1991;180:25–30.
Mattison GR, Glazer GM, Quint LE, et al. MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumors. AJR Am J Roentgenol. 1987;148:711–715.
Lee J, Jeong WK, Lim HK, et al. Focal nodular hyperplasia of the liver: contrast-enhanced ultrasonographic features with sonazoid. J Ultrasound Med. 2018;37:1473–1480.
Smith EA, Salisbury S, Martin R, et al. Incidence and etiology of new liver lesions in pediatric patients previously treated for malignancy. AJR Am J Roentgenol. 2012;199:186–191.
Bartolotta TV, Taibbi A, Matranga D, et al. Hepatic focal nodular hyperplasia: contrast-enhanced ultrasound findings with emphasis on lesion size, depth, and liver echogenicity. Eur Radiol. 2010;20:2248–2256.
Ungermann L, Elias P, Zizka J, et al. Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography. Eur J Radiol. 2007;63:290–294.
Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008;48:163–170.
Masetti R, Biagi C, Kleinschmidt K, et al. Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor? Eur J Pediatr. 2011;170:807–812.
Fajardo LF, Colby TV. Pathogenesis of veno-occlusive liver disease after radiation. Arch Pathol Lab Med. 1980;104:584–588.
Do RK, Shaylor SD, Shia J, et al. Variable MR imaging appearances of focal nodular hyperplasia in pediatric cancer patients. Pediatr Radiol. 2011;41:335–340.
Ji Y, Chen S, Xiang B, et al. Clinical features of focal nodular hyperplasia of the liver in children. J Pediatr Gastroenterol Nutr. 2016;62:813–818.
Gobbi D, Dall’Igna P, Messina C, et al. Focal nodular hyperplasia in pediatric patients with and without oncologic history. Pediatr Blood Cancer. 2010;55:1420–1422.
Zarfati A, Chambers G, Pio L, et al. Management of focal nodular hyperplasia of the liver: experience of 50 pediatric patients in a tertiary center. J Pediatr Surg. 2020;55:1885–1891.

Auteurs

Sook Min Hwang (SM)

Department of Radiology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University.

So-Young Yoo (SY)

Department of Radiology and Center for Imaging Science, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, Korea.

Woo Kyoung Jeong (WK)

Department of Radiology and Center for Imaging Science, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, Korea.

Min Woo Lee (MW)

Department of Radiology and Center for Imaging Science, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, Korea.

Tae Yeon Jeon (TY)

Department of Radiology and Center for Imaging Science, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, Korea.

Ji Hye Kim (JH)

Department of Radiology and Center for Imaging Science, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, Korea.

Classifications MeSH